Market Tracker

10/18 8:43am ET

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.19
Delayed Data
As of Oct 17
 +0.02 / +0.63%
Today’s Change
1.22
Today|||52-Week Range
5.55
+124.65%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close3.17
Today’s open3.23
Day’s range3.15 - 3.26
Volume8,612
Average volume (3 months)57,024
Market cap$36.0M
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)+86.59%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+29.92%
P/E ratioNM
Price/Sales4.43
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.12-3.66%
VKTXViking Therapeutics ...-0.02-0.96%
SLNOSoleno Therapeutics ...-0.08-3.30%
CATBCatabasis Pharmaceut...-0.07-2.97%
Data as of 10/17/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$3.5M
Annual profit (last year)-$2.7M
Net profit margin-75.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts